ReviewFrontiers in cellular and infection microbiology2026

Adenoviral E3/49K: CD45-targeted immune evasion and therapeutic potential.

Mark Windheim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.